4.5 Article

Activation of GSK-3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats

Journal

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 21, Issue 12, Pages 3515-3528

Publisher

WILEY
DOI: 10.1111/jcmm.13262

Keywords

glycogen synthase kinase-3; acetylcholine; choline acetyltransferase; nuclear factor-kappa B; alzheimer disease

Funding

  1. Natural Science Foundation of China [91132305, 81261120570, 81301101, 81400948, 81528007]
  2. MOST [2016YFC1305800]

Ask authors/readers for more resources

The cholinergic impairment is an early marker in Alzheimer's disease (AD), while the mechanisms are not fully understood. We investigated here the effects of glycogen synthase kinse-3 (GSK-3) activation on the cholinergic homoeostasis in nucleus basalis of Meynert (NBM) and frontal cortex, the cholinergic enriched regions. We activated GSK-3 by lateral ventricular infusion of wortmannin (WT) and GF-109203X (GFX), the inhibitors of phosphoinositol-3 kinase (PI3-K) and protein kinase C (PKC), respectively, and significantly decreased the acetylcholine (ACh) level via inhibiting choline acetyl transferase (ChAT) rather than regulating acetylcholinesterase (AChE). Neuronal axonal transport was disrupted and ChAT accumulation occurred in NBM and frontal cortex accompanied with hyperphosphorylation of tau and neurofilaments. Moreover, ChAT expression decreased in NBM attributing to cleavage of nuclear factor-kappa B/p100 into p52 for translocation into nucleus to lower ChAT mRNA level. The cholinergic dysfunction could be mimicked by overexpression of GSK-3 and rescued by simultaneous administration of LiCl or SB216763, inhibitors of GSK-3. Our data reveal the molecular mechanism that may underlie the cholinergic impairments in AD patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway

Dan Zhang, Song Han, Shizun Wang, Yanlin Luo, Li Zhao, Junfa Li

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Article Endocrinology & Metabolism

Identification of Protein Kinase C Isoforms Involved in Type 1 Diabetic Encephalopathy in Mice

Jiayin Zheng, Yue Wang, Song Han, Yanlin Luo, Xiuli Sun, Ning Zhu, Li Zhao, Junfa Li

JOURNAL OF DIABETES RESEARCH (2018)

Article Neurosciences

Phosphorylation of p38 MAPK mediates hypoxic preconditioning-induced neuroprotection against cerebral ischemic injury via mitochondria translocation of Bcl-xL in mice

Li Zhao, Xu Liu, Jing Liang, Song Han, Yue Wang, Yanling Yin, Yanlin Luo, Junfa Li

BRAIN RESEARCH (2013)

Article Neurosciences

GLYCOGEN SYNTHASE KINASE-3 REDUCES ACETYLCHOLINE LEVEL IN STRIATUM VIA DISTURBING CELLULAR DISTRIBUTION OF CHOLINE ACETYLTRANSFERASE IN CHOLINERGIC INTERNEURONS IN RATS

L. Zhao, C. -B. Chu, J. -F. Li, Y. -T. Yang, S. -Q. Niu, W. Qin, Y. -G. Hao, Q. Dong, R. Guan, W. -L. Hu, Y. Wang

NEUROSCIENCE (2013)

Article Medicine, Research & Experimental

Intracranial Epstein-Barr virus infection appearing as an unusual case of meningitis in an immunocompetent woman: a case report

Yue Wang, Qian Dong, Yu-dan Chen, Wen-li Hu, Li Zhao

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Article Neurosciences

cPKCγ Deficiency Exacerbates Autophagy Impairment and Hyperphosphorylated Tau Buildup through the AMPK/mTOR Pathway in Mice with Type 1 Diabetes Mellitus

Jiayin Zheng, Yue Wang, Yue Liu, Song Han, Ying Zhang, Yanlin Luo, Yi Yan, Junfa Li, Li Zhao

Summary: This study found that knockout of cPKCγ in the hippocampal neurons of T1DM mice increased the phosphorylation of Tau at Ser214 and neurofibrillary tangles. cPKCγ deficiency reduced autophagy levels and cognitive impairment in T1DM mice. cPKCγ promotes autophagy through the AMPK/mTOR signaling pathway, reducing the phosphorylation of Tau at Ser214 and neurofibrillary tangles.

NEUROSCIENCE BULLETIN (2022)

Article Medicine, Research & Experimental

Mitochondrial pyruvate carrier 1 alleviates hypoxic-ischemic brain injury in rats

Yue Liu, Yuan Yuan, Yi Yan, Ruyue Wang, Zhaohui Wang, Xiao Liu, Ying Zhang, Jianyu Hua, Yue Wang, Li Zhao

Summary: This research aims to investigate the impact of mitochondrial dysfunction on cerebral ischemia and explore the role of mitochondrial pyruvate carrier 1 (MPC1) in this process. The study demonstrates that MPC1 can exert a neuroprotective effect on cerebral ischemia by attenuating oxidative stress, mitochondrial dysfunction, calcium overload, and autophagy. The findings suggest that MPC1-related genes identified through RNA-seq may serve as a novel therapeutic target for cerebral ischemia.

LIFE SCIENCES (2023)

No Data Available